Fluorescent lymphography for thoracic duct identification: Initial experience of a simplified and feasible ICG administration.
ICG
fluorescence
robotic oesophagectomy
robotic surgery
thoracic duct
Journal
The international journal of medical robotics + computer assisted surgery : MRCAS
ISSN: 1478-596X
Titre abrégé: Int J Med Robot
Pays: England
ID NLM: 101250764
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
revised:
30
12
2021
received:
15
04
2021
accepted:
01
02
2022
pubmed:
5
2
2022
medline:
27
4
2022
entrez:
4
2
2022
Statut:
ppublish
Résumé
Indocyanine green (ICG) lymphography can be performed to obtain realtime fluorescent images of the thoracic duct (TD). The injection of ICG into the inguinal nodes usually is ultrasound-guided. Our hypothesis was to simplify the ICG administration until making it executable by unqualified personnel without ultrasound guidance. From October 2019 to October 2021 we enroled 18 patients. ICG was injected with a 25 Gauge needle in the subcutaneous tissue of the inguinal region bilaterally 14-16 h before surgery. The TD was visualised in every case considered. The easy switching between fluorescence and white light visualization facilitated the identification and dissection of the TD avoiding involuntary injuries. The simplified ICG administration to identify TD during oesophagectomy is easy to perform, does not require specifically trained staff, is not time demanding and has comparable results to the procedure performed under ultrasound guide.
Substances chimiques
Coloring Agents
0
Indocyanine Green
IX6J1063HV
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2380Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
Alexiou C. Chylothorax following oesophagogastrectomy for malignant disease. Eur J Cardio Thorac Surg. 1998;14(5):460-466. https://doi.org/10.1016/S1010-7940(98)00230-9
Mboumi IW, Reddy S, Lidor AO. Complications after esophagectomy. Surg Clin. 2019;99(3):501-510. https://doi.org/10.1016/j.suc.2019.02.011
Rasmussen SR, Nielsen RV, Fenger AS, Siemsen M, Ravn HB. Postoperative complications and survival after surgical resection of esophageal squamous cell carcinoma. J Thorac Dis. 2018;10(7):4052-4060. https://doi.org/10.21037/jtd.2018.07.04
Tagaya N, Yamazaki R, Nakagawa A, et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg. 2008;195(6):850-853. https://doi.org/10.1016/j.amjsurg.2007.02.032
Vecchiato M, Martino A, Sponza M, et al. Thoracic duct identification with indocyanine green fluorescence during minimally invasive esophagectomy with patient in prone position. Dis Esophagus. 2020;33(12):doaa030. https://doi.org/10.1093/dote/doaa030
Kamiya K, Unno N, Konno H. Intraoperative indocyanine green fluorescence lymphography, a novel imaging technique to detect a chyle fistula after an esophagectomy: report of a case. Surg Today. 2009;39(5):421-424. https://doi.org/10.1007/s00595-008-3852-1
Matsutani T, Hirakata A, Nomura T, et al. Transabdominal approach for chylorrhea after esophagectomy by using fluorescence navigation with indocyanine green. Case Rep Surg. 2014;2014:464017. https://doi.org/10.1155/2014/464017
Kaburagi T, Takeuchi H, Oyama T, et al. Intraoperative fluorescence lymphography using indocyanine green in a patient with chylothorax after esophagectomy: report of a case. Surg Today. 2013;43(2):206-210. https://doi.org/10.1007/s00595-012-0391-6
Shah RD, Luketich JD, Schuchert MJ, et al. Postesophagectomy chylothorax: incidence, risk factors, and outcomes. Ann Thorac Surg. 2012;93(3):897-904. discussion 903-904. https://doi.org/10.1016/j.athoracsur.2011.10.060
Yeung JC. Management of complications after esophagectomy. Thorac Surg Clin. 2020;30(3):359-366. https://doi.org/10.1016/j.thorsurg.2020.04.002
Grimminger PP, Goense L, Gockel I, et al. Diagnosis, assessment, and management of surgical complications following esophagectomy. Ann N Y Acad Sci. 2018;1434(1):254-273. https://doi.org/10.1111/nyas.13920
Varshney VK, Suman S, Garg PK, Soni SC, Khera PS. Management options for post-esophagectomy chylothorax. Surg Today. 2021;51(5):678-685. https://doi.org/10.1007/s00595-020-02143-y
Fujita T, Sato T, Sato K, Hirano Y, Fujiwara H, Daiko H. Clinical manifestation, risk factors and managements for postoperative chylothorax after thoracic esophagectomy. J Thorac Dis. 2019;11(S3):S198-S201. https://doi.org/10.21037/jtd.2019.02.31
Zhang SS, Yang H, Luo KJ, et al. The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. Br J Cancer. 2013;109(11):2894-2903. https://doi.org/10.1038/bjc.2013.666
Miao L, Zhang Y, Hu H, et al. Incidence and management of chylothorax after esophagectomy. Thorac Cancer. 2015;6(3):354-358. https://doi.org/10.1111/1759-7714.12240
Dougenis D, Walker WS, Cameron EW, Walbaum PR. Management of chylothorax complicating extensive esophageal resection. Surg Gynecol Obstet. 1992;174(6):501-506.
Lai FC, Chen L, Tu YR, Lin M, Li X. Prevention of chylothorax complicating extensive esophageal resection by mass ligation of thoracic duct: a random control study. Ann Thorac Surg. 2011;91(6):1770-1774. https://doi.org/10.1016/j.athoracsur.2011.02.070
Choh CTP, Khan OA, Rychlik IJ, McManus K. Does ligation of the thoracic duct during oesophagectomy reduce the incidence of post-operative chylothorax? Int J Surg. 2012;10(4):203-205. https://doi.org/10.1016/j.ijsu.2012.03.011